The G-protein-coupled receptor superfamily (GPCRs) is comprised of a large group of membrane proteins involved in a wide range of physiological signaling processes. The functional switch from a quiescent to an active conformation is at the heart of GPCR action. The GPCR rhodopsin has been extensively studied due to its key role in scotopic vision. The ground state chromophore, 11-cis-retinal, holds the transmembrane region of the protein in the inactive conformation. Light induces cis-trans isomerization and rhodopsin activation. Here we show that rhodopsin regenerated with a ring constrained 11cis-retinal analog undergoes photoisomerization; however, it remains marginally active because isomerization occurs without the chromophore-induced conformational change of the opsin moiety. Modeling the locked chromophore analogs in the active site of rhodopsin suggests that the β-ionone ring rotates but is largely confined within the binding site of the natural 11-cis-retinal chromophore. This constraint is a result of the geometry of the stable 11-cislocked configuration of the chromophore analogs. These results suggest that the native chromophore cis-trans isomerization is merely a mechanism for repositioning of the β-ionone ring that ultimately leads to helix movements and determines receptor activation. 4 INTRODUCTION: Binding of specific ligands to the extracellular or conserved seven α-helical transmembrane domains of G-protein-coupled receptors causes conformational changes that act as a switch to relay the signal to heterotrimeric guanine nucleotide-binding proteins (G-proteins), which in turn evoke subsequent intracellular responses. Understanding the precise conformational transformation of an inactive GPCR into an activated form capable of interacting with a Gprotein is a key problem in elucidating the molecular steps of cell-surface receptor signaling. Rhodopsin, a member of the GPCR family, is involved in photon absorption in retinal rod cells and activation of transducin, a specific Gprotein (1). Rhodopsin is a bipartite molecule composed of the protein opsin (~40 kDa) covalently linked to 11-cis-retinal (a derivative of vitamin A) through a protonated Schiff base with Lys 296 located in transmembrane helix VII (H-VII) (2-4). The determination of the X-ray structure of the first GPCR, rhodopsin, provides new insights into the ground state conformation of this receptor (5). The inactive conformation of rhodopsin is stabilized by the 11-cis-retinal chromophore. The positive charge of the Schiff base linkage is placed in a highly hydrophobic environment and is neutralized by Glu 113 (6,7) . Absorption of a photon by the chromophore causes photoisomerization around the C 11 -C 12 double bond and the formation of all-trans-retinylidene (8). Photoisomerization of the chromophore to the all-trans-isomer causes changes in the polyene chain of the chromophore, including reorientation of the C 9 -and C 13 -methyl groups and repositioning of the β-ionone ring, that ultimately leads to deprotonation of the
Schiff base, and changes at the cytoplasmic surface of rhodopsin (3) . These changes are sufficient to drive a conformational change of the protein, and transient activation of opsin, before the Schiff base hydrolyzes to release alltrans-retinal from opsin. The atomic resolution structures of these intermediates
are not yet available.
The activation process of rhodopsin has been investigated by biochemical methods, and several models have been proposed. In one of the most widely accepted models, it is proposed that photoactivation involves a critical proton transfer between the protonated Schiff base and the glutamate counter ion.
However, it is clear that the structural constraint imposed on opsin by the protonated Schiff base-counterion interaction only partially can account for the activation process (4) . The photoactivation process could also involve the repositioning of the methyl groups of all-trans-retinal, particularly movement of the methyl group at C 9 could cause activation by triggering a conformational change in opsin (2) . Retinal analogs, with a bridge between C 10 and C 13 of 1-4 carbons that prevents isomerization around the C 11 -C 12 bond, stabilize opsin in its inactive conformation (or minimally active) even under light conditions (9) (10) (11) .
It is believed that lack of isomerization or incomplete isomerization around the C 11 -C 12 bond in the polyene chain of the retinal analog is the cause of this lack of rhodopsin activation. Alternatively, the repositioning of the β-ionone ring of the chromophore may be needed to trigger conformational changes that lead to the formation of the active form of rhodopsin. We revisited this problem using ring constrained ("locked") retinal analog regenerated rhodopsins and the 3-dimensional structure of rhodopsin in the ground state to understand what changes within the chromophore binding pocket are allowed without substantial receptor activation.
EXPERIMENTAL PROCEDURES
Synthesis: Two isomeric cyclic ketones (9-cis-and 9-trans-) containing four double bonds were prepared by condensation between β-ionone and 3-methoxy-2-cyclohexenone followed by subsequent reduction, hydrolysis and water elimination (12) . Horner-Emmons reaction of the ketone followed by DIBAL-H reduction afforded an isomeric mixture of four 11-cis-locked retinal analogs in approximately equal ratio. The mixture was separated using isocratic normal phase HPLC with 4% ethyl acetate/hexane. Each fraction was additionally rechromatographed using the same conditions to achieve the final isomeric purity of 95-98%.
Photoisomerization of 11-cis-Locked Retinal Analogs of Rhodopsin: Rod outer segments membranes from 50 retinas (~40 mg of rhodopsin) were suspended in 20 ml H 2 O. The suspension was centrifuged at 110,000g for 30 min. The pellet was resuspended in 20 ml of 20 mM 1,3-bis[tris(hydroxymethyl)methylamino]propane (BTP), pH 7.4, 0.1 M NaCl, and 16 mM NH 2 OH (freshly prepared), and the mixture was placed on ice and bleached with a 250 watt lamp at a distance of 10 cm for 30 min. The bleached rhodopsin (opsin) was extensively washed with 20 mM BTP, pH 7.4, 0.1 M NaCl and finally suspended in 10 ml of the same buffer. The above opsin suspension (350 µl) was mixed with ~54 nmol of 11-cis-locked retinal analog in DMF or DMF only (9 µl) as a control, and the mixture was incubated on a nutator at room temeparture overnight under dim red light conditions. The reconstituted rhodopsin analog was then solubilized with 10 mM n-dodecyl-β-D-maltoside, and the solubilization mixture was centrifuged at 86,000g for 15 min. The resulting supernatant was loaded onto 0.7 ml of Concanavalin A-Sepharose 4B (Sigma) equilibrated with buffer A (20 mM BTP, pH 7.4, 10 mM n-dodecyl-β-D-maltoside, 0.1 M NaCl) in a glasswool-plug Pasteur pipet at 10 o C. The column was washed with 15 column volumes of buffer A (monitored by the disappearance of UV absorption at ~350 nm), and the fractions containing rhodopsin analogs were eluted with 700 µl of 300 mM methyl α-D-mannopyranoside in buffer A. The purified rhodopsin analogs were bleached twice by a photographic flash-light from a 5 cm distance. The retinoids were converted to their oximes by adding 300 µl MeOH and 150 µl 0.4 M NH 2 OH, pH 6.5, and the oximes were extracted twice with 500 µl of hexane. Retinoids were analyzed by normal phase HPLC (Alltech, silica 5µ, 2.1x250 mm) with 4% ethyl acetate/hexane at a flow rate of 0.5 ml/min (13) .
Purification of transducin and the activity assay. Transducin was purified from bovine ROS as described previously (14) . The activity of transducin was determined by following the light-dependent binding of [ 35 S]GTPγS (2 Ci/mmol) at FTIR spectroscopy. To prepare the FTIR samples, 24 µM opsin membranes (16) were incubated over night with 240 µM native 11-cis-retinal or with the mixture of locked retinal analogs in BTP buffer (130 mM NaCl, 20 mM BTP, pH 7.5, 1 mM MgCl 2 ). Suspensions of membranes were centrifuged for 25 min at 100,000 g, yielding 2.2 mM rhodopsin in the pellet (from absorption at 500 nm). The buffer solution was removed and the pellet transferred to a 30 mm-diameter temperature controlled transmission cell with two BaF 2 windows and a 5 µm PTFE-gasket. The spectra were recorded using a Bruker ifs 66v spectrometer (17) . Measurements were performed at pH 7.5 and 25°C. For both samples, Meta II minus rhodopsin difference spectra were generated. four locked analogs together with Lys 296 were optimized with the rest of the protein fixed. The same procedure was applied to residues near (4.5 Å) to above movable part. Then the complete protein structure was optimized without constraints. Visualizations were done on portion of rhodopsin confined to a 4.5 Å radial distance from the retinal and Lys 296 atoms. It was necessary to remove some of the residues to show the retinal inside the cavity. Additional information is provided in the figure captions.
RESULTS AND DISCUSSION
To obtain additional insight into the activation mechanism, we prepared four retinal analogs with a 2-carbon bridge linking C 10 and C 13 of retinal as part of a cyclohexene ring (10,11,21)(Experimental Procedures) that permanently fixes the C 11 -C 12 bond in the cis configuration ( Fig 1A) . 11-cis-Locked isomers were separated by normal phase HPLC (Fig. 1B) , and their structures were confirmed by mass spectrometry (Fig. 1C ), and NMR (not shown).
Photoisomerization of Rhodopsin Regenerated with 11-cis-Locked

Isomers.
All 11-cis-locked retinal isomers were stable in solution; however, these isomers could be converted into each other in solution by a short bleach (for example, bleaching of 11-cis-locked isomer 3 is shown in Figs. 2A and B) , with isomer 1 produced in the lowest abundance. To ensure quantitative extraction, particularly in the presence of biological membranes (see below), each isomer was pre-column derivatized with hydroxylamine and anti-oximes were fully chromatographically resolved, while syn-oximes were only partially resolved ( Fig.   2B ). As shown in Fig. 3 , all four 11-cis-locked isomers in solution individually give rise to a mixture of anti-oximes after photobleaching. In contrast, when reacted with opsin in native membranes, in the absence of bleaching, 9,11,13-tri-cis-(1), 11,13-di-cis-(2), and 9,11-di-cis-(4) locked retinal analogs spontaneously isomerized to each other ( Fig. 3 ) due to isomerization around the C 13 -C 14 bond.
This observation is consistent with earlier studies with di-cis retinals that showed that the cis C 13 -C 14 bond is destabilized upon reaction with opsin (22) . 11-cis-Locked analog 3 did not isomerize after binding to opsin ( Fig. 3 ). Bleaching of 11,13-di-cis (analog 2) and 11-cis-locked (analog 3) rhodopsin produced isomerization around the C 9 -C 10 double bond. Quantitative analysis of the 9,11,13-tri-cis and 9,11-di-cis locked retinal regenerated rhodopsin was more difficult due to isomerization in the dark; however, all isomers were produced These differences in the specificity between these two dehydrogenases result from the recognition of the C 13 -C 14 -C 15 carbon triad configuration in addition to the β-ionone ring ( Fig. 3) . Thus, rhodopsin's infidelity in discriminating the locked analogs results from the relaxed structural constraints in the active site rather than the structural flexibility of these hydrophobic analogs.
These results surprisingly reveal that rhodopsin regenerated with 11-cislocked retinals readily undergoes photoisomerization ( Fig. 3 ) without or marginal activation of transducin (Table 1) (11, 21) . These data are consistent with earlier observation that the spectrum of rhodopsin regenerated with the 3 locked analog changes upon illumination (21) . Similar absorption maxima of rhodopsin regenerated with analogs (conformational sensitive opsin shift), ranging from 494-510 nm (data not shown), suggest that the interaction of opsin and the chromophore is not considerably changed as a result of the different configuration around C 9 and C 13 double bonds found among these analogs. The structural changes in the retinal analogs bound to opsin upon isomerization and how opsin accommodates such changes were investigated utilizing the recently solved high-resolution three-dimensional structure of rhodopsin (5) .
Locked analogs in the active site of rhodopsin.
All four locked retinal analogs were modeled in the active site of rhodopsin None of the spectral changes was observed in control measurements on the retinal analogs in alcoholic solution or when added to aqeous BSA solution (data not shown). We conclude that, in agreement with the extraction experiments, light-induced changes in the chromophore (different from those seen with C 11 -C 12 double bond isomerization) do occur, but the activating structural changes in opsin are absent.
The orientation of the β-ionone ring of 11-cis-retinal in rhodopsin
The orientation of the β-ionone ring of 11-cis-retinal in the crystal structure of bovine rhodopsin (5) (see more detailed analysis in (24)) is in disagreement with the most recent NMR-derived structure of the chromophore as proposed by Grobner and colleagues (25) . NMR and crystal structure models are very similar for the polyene chain; however, the β-ionone ring is flipped from the 6s-cis (C 5 C 6 C 7 C 8 torsion angle -72.35 seen in the crystal structure) to the 6s-transconfiguration observed by NMR. Accommodation of both the 6s-trans-and the 6s-cis-conformations in the active site would be possible if the key interaction between opsin and the β-ionone ring of the chromophore (5) does not depend on the specific recognition of three methyl groups of the chromophore (26) . Importantly, Ito and colleagues have showed that rhodopsin can be regenerated with 6s-cis and 6s-trans-11-cis-retinal (27, 28) .
Borhan and colleagues employing a photolabeling approach using an 11-cislocked analog similar to 1 but carrying a 3-diazo-group on the β-ionone ring, identified Trp 265 as being in close proximity to the β-ionone ring after photoactivation of the cross-linker (29)(see (5) and (Fig. 4B) ). Based on our studies, it now seems likely that the 3-diazo-chromophore analog also undergoes photoisomerization to give a mixture of isomer analogous to 1-4. Our modeling studies suggest that only 2 of these "locked" analogs (1 and 3) would cross-link with Trp 265 on helix VI, while 2 others (2 and 4) , resulting from β-ionone flipping, would position the diazo group away from Trp 265 . The full analysis of the crosslinking studies is complicated by the fact that stoichiometric cross-linking to Trp 265 was not achieved and the likely possibility that all 4 chromophore analogs would be present after photolysis (29) . Upon illumination of another retinal analog that was photoisomerized to the all-trans-configuration, a clear movement of the chromophore ring was observed, resulting in cross-linking to Ala 169 on H-IV (Fig.   4D ).
The role of Gly 121 and C 9 methyl group of retinal
Photoisomerization of rhodopsin reconstituted with locked analogs of retinal but without activation provides additional evidence that changes in the polyene chain configuration and relocation of the C 9 methyl group are insufficient for activation. This observation is in agreement with an earlier finding that rhodopsin regenerated with an acyclic analog of retinal, lacking a functional β-ionone ring, is not activated upon illumination (30) . It has been proposed that Gly 121 is a contact residue with the C 9 methyl of the chromophore (31); however, the X-ray structure shows that Gly 121 is more than 4 Å away from the chromophore (Fig. 4B and C) .
However, Gly 121 could affect packing of residues in the active site in such a way that when Gly 121 is replaced by other amino acids and 11-cis-retinal by analogs containing 9-aliphatic group larger than methyl, this raises the dark activity of rhodopsin depending on the position 121 side-chain size and the size of the C 9 substituant of the retinal (31) . The C 9 methyl group is, however, essential for complete and efficient transformation of rhodopsin from the early photoproduct to the activated form (32, 33) . This observation can be explained by less constrained fitting of 9-desmethyl-all-trans-retinal into the 11-cis-retinylidene binding site as compared to all-trans-retinal (data not shown).
The activation mechanism of rhodopsin.
Based on this and previous work, it appears that photoisomerization of the 11-cis-chromophore to the all-trans-configuration, causes a twist of the chromophore within the 11-cis-retinylidene binding pocket (intermediates known as Photo, Batho) ( Fig. 4C) . Our results suggest that in the next stage, cis-trans isomerization causes repositioning of the β-ionone ring that ultimately determines the fate of the receptor activation states. If the photoisomerized chromophore is in an extended conformation, this repositioning of the β-ionone ring is followed by reorganization of transmembrane H-III, and subsequently H-VI (residues 244-276) moves away from H-III (termed Lumi, and MI rhodopsins, respectively). This new position of the β-ionone ring initiates, in turn, a sequence of conformational changes (summarized in (34) ) that produces the activated receptor (metarhodopsin II) (Fig. 4D) . These changes cause deprotonation of the chromophore Schiff base and concurrent protonation of Glu 113 , and changes on the cytoplasmic surface of rhodopsin (34) . If the photoisomerization occurs within the 11-cis-retinal binding site, like observed with the locked analogs, despite of undergoing initial photoactivation (35) and isomerization (as shown in this report), there is no (or marginal) activation ( Fig. 5 ; Table I ). In addition, demonstrated plasticity of the binding site, in accommodating different cis-conformers of retinal ( Fig. 4D) , provides an explanation for the ability to regenerate rhodopsin with drastically different chromophore isomers such as 11-cis-retinal, 9-cis-retinal, 7cis-retinal and several di-cis derivatives. 
